Fig. 1From: Prognostic effect of stress hyperglycemia ratio on patients with severe aortic stenosis receiving transcatheter aortic valve replacement: a prospective cohort studyAssociation of SHR with different endpoints among patients who treated with TAVR. A: All-cause mortality-unadjusted. B: cardiovascular mortality or readmission for heart failure-unadjusted. C: MACE-unadjusted. D: All-cause mortality-adjusted. E: Cardiovascular mortality and rehospitalization for heart failure-adjusted. F: MACE-adjusted. SHR stress hyperglycemia ratio, HR hazard ratio, CI confidence interval, MACE major adverse cardiovascular eventsBack to article page